Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view-Reference-Cited by-同舟云学术

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

Published:2018-09-21 Issue:1 Volume:8 Page:
ISSN:2191-1991
Container-title:Health Economics Review
language:en
Short-container-title:Health Econ Rev

Author:

Giuliani Giovanni,Chassagnol Frederic,Traub David,Gyldmark Marlene,Hebborn Ansgar,Ducournau Pierre,Ruof Jörg^ORCID

Funder

F. Hoffmann-La Roche

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s13561-018-0201-y.pdf

Reference19 articles.

1. Gazzetta Ufficiale; 2004; Anno 145o, Numero 228. http://www.agenziafarmaco.gov.it/sites/default/files/DM_2004_245.pdf . (Access 20 Dec 2017).

2. République Française. Le Service Public De La Diffusion du Droit. Loi no 2004–810 du 13 août 204 page 14598 texte no 2 https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000625158&dateTexte=&categorieLien=id . (Access 20 Dec 2017).

3. Gemeinsamer Bundesausschuss http://www.english.g-ba.de/benefitassessment/information/#2 . (Access 20 Dec 2017).

4. European Commission: Strengthening of the EU cooperation on Health Technology Assessment (HTA). Online pubic consultation report. https://ec.europa.eu/health/sites/health/files/technology_assessment/docs/20161020_frep_en.pdf . (Access 20 Feb 2018).

5. Berntgen M, Gourvil A, Pavlovic M, et al. Improving the contribution of regulatory assessment reports to health technology assessments – a collaboration between the European medicines agency and the European network for HealthTechnology assessment. Value Health. 2014;17:634–41.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries;Future Oncology;2024-04-25

2. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains;International Journal of Technology Assessment in Health Care;2023

3. Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment Bodies;Value in Health;2022-10

4. The ecosystem of health decision making: from fragmentation to synergy;The Lancet Public Health;2022-04

5. Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study;Frontiers in Pharmacology;2020-12-03